相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation
Yongjun Quan et al.
CANCER CELL INTERNATIONAL (2022)
Inherited TP53 Variants and Risk of Prostate Cancer
Kara N. Maxwell et al.
EUROPEAN UROLOGY (2022)
Enhanced autophagy and NFE2L2/NRF2 pathway activation in SPOP mutation-driven prostate cancer
Kun Gao et al.
AUTOPHAGY (2022)
SPOP-mutant prostate cancer: Translating fundamental biology into patient care
Tiziano Bernasocchi et al.
CANCER LETTERS (2022)
Stemness-related LncRNA pair signature for predicting therapy response in gastric cancer
Quan Jiang et al.
BMC CANCER (2021)
UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications
Yingxue Gao et al.
CANCER LETTERS (2021)
DNMT3A epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer
Monica Mancini et al.
CARCINOGENESIS (2021)
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
Matthew P. Deek et al.
EUROPEAN UROLOGY (2021)
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Enyong Dai et al.
MOLECULAR CANCER (2021)
Analysis of RNA m6A methylation regulators and tumour immune cell infiltration characterization in prostate cancer
Yue Zhao et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2021)
m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer
Bo Zhang et al.
MOLECULAR CANCER (2020)
Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing
Xiaoshi Ma et al.
MOLECULAR CANCER (2020)
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer
Shuai Gao et al.
NATURE GENETICS (2020)
Targeting LSD1 and FOXA1 in prostate cancer
Soleilmane Omarjee et al.
NATURE GENETICS (2020)
DOT1L in prostate cancer
Tim Thomas
NATURE REVIEWS UROLOGY (2020)
Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer
R. Vatapalli et al.
NATURE COMMUNICATIONS (2020)
Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer
Yunfeng Bai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer
Qipeng Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer
Yangjun Zhang et al.
MEDICAL SCIENCE MONITOR (2019)
SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer
Manuel Viotti et al.
JOURNAL OF CELL BIOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer
Lanbo Xiao et al.
CANCER RESEARCH (2018)
NSD2 is a conserved driver of metastatic prostate cancer progression
Alvaro Aytes et al.
NATURE COMMUNICATIONS (2018)
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
Jung Kim et al.
CELL REPORTS (2018)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
Sheng Yu Ku et al.
SCIENCE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Writing, erasing and reading histone lysine methylations
Kwangbeom Hyun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
Etienne Dardenne et al.
CANCER CELL (2016)
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Himisha Beltran et al.
NATURE MEDICINE (2016)
Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy
Michael A. Kozminski et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali et al.
PLOS MEDICINE (2016)
Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2
Admire Matsika et al.
PATHOLOGY (2015)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Histone Lysine-Specific Methyltransferases and Demethylases in Carcinogenesis: New Targets for Cancer Therapy and Prevention
Xuejiao Tian et al.
CURRENT CANCER DRUG TARGETS (2013)
SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen Receptor Transcription
Cheng Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
Houjian Cai et al.
CANCER RESEARCH (2012)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
Histone methylation: a dynamic mark in health, disease and inheritance
Eric L. Greer et al.
NATURE REVIEWS GENETICS (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression
F. Babbio et al.
ONCOGENE (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
Histone arginine methylation
Alessandra Di Lorenzo et al.
FEBS LETTERS (2011)
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
Scott E. Eggener et al.
JOURNAL OF UROLOGY (2011)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
The complex language of chromatin regulation during transcription
Shelley L. Berger
NATURE (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
The role of chromatin during transcription
Bing Li et al.
CELL (2007)
The diverse functions of histone lysine methylation
C Martin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
The nucleosome: From genomic organization to genomic regulation
S Khorasanizadeh
CELL (2004)